Skip to Main Content

Paper Details

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
171
2021
Author NameAffiliation
Farhad RavandiThe University of Texas MD Anderson Cancer Center
John F DiPersioWashington University in St. Louis
  • 1 - 2

Datasets

Release 1.2